Oestrogen receptors (ERs) 
Introduction
Oestrogen receptors (ERs) are key mediators of oestrogen function and play roles in many pathological processes, including carcinogenesis [1] . Although the roles of ER␣ in carcinogenesis are relatively well understood, the roles of ER␤ remain uncertain. This is partly because analyses have been confused by consistent discrepancies between ER␤ expression at mRNA and protein levels in breast tissue [2] [3] , leading to difficulties in interpreting mRNA expression data. In addition, ER␤ is expressed as five functionally distinct isoforms [4] , yet their roles have frequently been studied in combination at the level of total ER␤. ER␤ appears to be anti-proliferative and anti-apoptotic, and has been discussed as a tumour suppressor [5] [6] [7] [8] [9] . However, the specific effects of each isoform and whether these result from independent actions as transcription factors, or via hetero-dimerization with other receptors remain undetermined [10] [11] . An understanding of how ER␤ mRNA and protein levels relate, and how expression of each individual isoform is determined would provide useful background from which to assess the importance of each isoform more effectively.
In recent years, evidence has accumulated that deregulation of gene-specific translation plays a role in oncogenic transformation and tumour progression [12] . Translation occurs mainly by a capdependent mechanism with most regulation during initiation [13] . Initiation involves translational machinery binding to the mRNA cap and scanning along the 5Ј untranslated region (UTR) to the reading frame, where an initiation codon is recognized and protein synthesis starts [14] . 5ЈUTRs are thus placed in unique positions to regulate the efficiencies of recruitment and scanning of the translational machinery [15] . In particular, translation can be inhibited by the presence within 5ЈUTRs of upstream open reading frames (uORFs) or regions that form stable secondary structures [16] [17] . Many mRNAs have short 5ЈUTRs (composed of Ͻ50 nucleotides) that lack these motifs and consequently these 5ЈUTRs are thought to have little regulatory effect on translation [18] [19] . A substantial minority of mRNAs have long 5ЈUTRs [20] . Interestingly, many oncogenes and tumour suppressor genes express these atypically long or complex 5ЈUTRs, highlighting the importance of 5ЈUTRs in carcinogenesis [19] . Various cellular activities impact on the degrees of translational inhibition specified by these 5ЈUTRs allowing them to act as sites of regulation; for example changes in activities of translation factors eIF2␣ and eIF4E modify the influences of uORFs and secondary structures, respectively [21] [22] . It is also clear that further layers of regulation involving 5ЈUTRs exist, since many genes allow expression of alternative 5ЈUTRs resulting from use of multiple transcriptional start sites or from differential splicing [23] . Alternative 5ЈUTRs allow tissue-and/or stimuli-specific gene regulation by control of relative proportions of 5ЈUTRs with different translational properties in the total pool of mRNAs from that gene [24] .
Given the wide range of cancer-related genes that allow expression of potentially regulatory 5ЈUTRs and the frequency of expression of multiple 5ЈUTRs, deregulation of translation via inappropriate expression of UTR-regulatory factors and/or changes in relative
proportions of alternative 5ЈUTRs is thought to play a key role in carcinogenesis [12] . 
Our hypothesis was that regulation of ER␤ translation is responsible for the non-concordance of ER␤

Plasmids
pTH-GFPa and pcDNA3HA-eIF4E have been described previously [25] [26] . UTR reporters were created by cloning UTRs upstream of the GFP ORF in pTH-GFPa using a cloning strategy described previously [27] . Importantly 
Western blotting
This was performed as previously [27] 
Results
Alternative ER␤ 5UTRs are differentially expressed in human cells
We identified four alternative 5ЈUTRs for ER␤ from the literature [33] and from Genbank, which we have termed UTRa, UTRa-long, UTRb and UTRc. Figure 1( Fig. 1B) . Following on from our analysis of breast and lung tumours (Fig. 1D) , breast and lung cell lines were used for our analyses. Cells were transiently transfected (Fig. 3A) . Cells were transfected with equal copy numbers of the vectors and translational efficiency was analysed as before (Fig. 3B) Fig. 2A) (Fig. 4B) . We therefore concluded that secondary structure within these 5ЈUTRs was responsible for inhibition of translation, and that this inhibition, especially that specified by UTRc, can be overcome by highly active eIF4E -delineating a potential pathway for translational de-regulation of ER␤ in cancer. (Fig. 5A) . Importantly, the proteins are functionally distinct being associated with differential responses to anti-oestrogens and patient survival [28, [40] [41] [42] . We have investigated whether alternative ER␤ 5ЈUTRs are differentially associated with mRNAs for each ER␤
UTR exons (filled boxes), coding regions (open boxes), transcriptional (black arrows) and translational (ATG) start sites, intron sizes (kbp), and primers used for PCR analysis (grey arrows) are shown. (B) 5Ј ends of ER␤ mRNAs correspond to variable positions in exon (E) 0K and E0N. 5ЈRACE reactions were performed on two breast tumour samples (1 and 2). Products corresponding to the 5Ј end of E0K (UTRa) or 0N (UTRc) are shown; UTRa was only detected in tumour 1. These (and other) products were sequenced; the diagram shows sequence consistently included in transcripts (grey boxes) and sequence containing variable start sites (open boxes and double-headed arrows; variation for UTRa and UTRc spans 35 or 72 bases), with genomic locations with respect to the E1 ATG codon. (C) and (D) PCR analyses showed that
and either empty expression plasmids or plasmids allowing eIF4E over-expression. Western blot analysis was used to confirm expression of exogenous eIF4E in the appropriate co-transfected cells (Fig. 4A). Translational efficiencies of reporters were determined as before (Fig. 4B). As expected, the translational efficiency of the control reporter (GFP), which expresses a non-specialized 5ЈUTR, was not significantly altered in either cell line by eIF4E over-expression. This demonstrated that over-expression of eIF4E did not result in non-specific changes in translation. In contrast, translational efficiencies specified by each ER␤ 5ЈUTRs were increased. In HB2 cells, exogenous eIF4E enhanced translation from UTRa by 1.2-fold (P ϭ 0.004) and from UTRc by 1.8-fold (P ϭ 0.0008) (Fig. 4B). Increases were also seen in MCF7 cells (UTRa, 1.2-fold [P ϭ 0.047], UTRc 1.3-fold [P ϭ 0.004]) (Fig. 4B). It is worth emphasizing that the inhibitory effect of UTRc was relieved by exogenous eIF4E so effectively in HB2 cells that transcripts were translated as efficiently as uninhibited controls
Different 3 spliced isoforms are associated with particular 5UTRs
Having defined influences of ER␤ 5ЈUTRs and mechanisms involved using reporter assays, we were interested to examine whether 5ЈUTRs impacted on endogenous ER␤ protein. However, this question is complex since the ER␤ gene gives rise to multiple different ER␤ mRNA isoforms that code for different proteins (ER␤1-5). ER␤1, 2 and 5 are particularly relevant in breast cell lines and cancers, since ER␤3 is thought to be testis-specific [4] and ER␤4 is not expressed in the breast [39], and we focused on these. The protein isoforms have identical N-termini but different C-termini due to differential 3Ј splicing of their transcripts
Fig. 3 uORFs within UTRa and UTRc are responsible for inhibition of translation. (A) The start codons within the uORFs of UTRa or UTRc were mutated to UUG or AUC as shown in the context of UTR-GFP reporter constructs. UTRa and UTRc are shown with sequences encoded by E0K or 0N as open boxes (with unique uORFs) and by E1 as shaded boxes (containing uORF common to UTRs). (B) MCF7 cells were transfected with reporter constructs and translational efficiencies determined relative to GFP control. Error bars show the standard deviation of technical triplicates within a representative experiment. The statistical significance of the difference between the wild-type UTRs and each mutant is shown:
*P Ͻ 0.05, **P Ͻ 0.001.
isoform, and therefore would have separate influences on expression of each isoform.
To perform these analyses we synthesized cDNA using primers specific for ER␤1, 2 or 5 and a protocol to enhance primer specificity, thereby creating cDNA pools greatly enriched for each specific message of interest (Fig. 5A) (Fig. 5B) . In each case, cDNA pools were enriched for target isoforms, therefore in subsequent analyses we were able to examine relative expressions of 5ЈUTRs on transcripts for each isoform in isolation. Relative expression levels of 5ЈUTRs within these enriched cDNAs were then determined using real-time PCR for UTRa and UTRc (Fig. 5C-E (Fig. 5D) (Fig. 2) we concluded that the proportions of the UTRs may define the overall translational efficiencies for each isoform, and thereby contribute to defining each expression level.
and MDA-MB-231 cells (Fig. 5E), and UTRa containing ER␤5 mRNAs could not be detected in MDA-MB-231 cells. We concluded that mRNAs for each isoform have different and cell-type specific proportions of the two 5ЈUTRs. Since we have also shown that ER␤ 5ЈUTRs determine greatly differing translational efficiencies
5UTRs define how eIF4E impacts on expression of ER␤ isoforms in tumours
Since ER␤ 5ЈUTRs specified different degrees of response to eIF4E (Fig. 4) (Fig. 4) , and since these were over-represented in mRNAs for ER␤1 (Fig. 5) [28] [29] 31] . Due to core loss during processing; a well recognized problem associated with TMAs, scores were available for 408 cases. Representative staining patterns are shown in Fig. 6 . For eIF4E, tumour stroma and normal tissue were negative while positive staining within tumour cells was generally cytoplasmic, although nuclear staining was noted in some cases (data not shown [29] ). All ER␤ isoforms investigated were expressed in epithelial and some stromal cell nuclei. In some cases, additional cytoplasmic ER␤1 expression was seen and cytoplasmic ER␤2 was occasionally detected in the absence of nuclear immunoreactivity (data not shown, but shown and discussed in our previous work [28] ). The full range of scores was observed for each antigen, with scores of 5, 6, 8 , and 8 occurring most frequently for eIF4E, ER␤1, ER␤2 and ER␤5, respectively. Associations between markers were examined using Spearman's correlation tests (Table 1) . Over the whole cohort (n ϭ 408), eIF4E expression showed a positive association with ER␤1 expression (correlation co-efficient r ϭ 0.28; P Ͻ 0.0001), although no association with ER␤2 or ER␤5. We next examined associations between these markers in two patient groups, those who experienced recurrences (n ϭ 74) and those that did not (n ϭ 334), since we expected correlations to differ with cell-specific factors (Fig. 5) , and since both eIF4E [36] and ER␤ [28] influence the likelihood of recurrences. In the nonrecurrence group (n ϭ 334), eIF4E expression showed a positive 
Discussion
We have investigated the abilities of ER␤ 5ЈUTRs to allow posttranscriptional regulation of ER␤ expression, and -via differential effects on ER␤ isoforms -ER␤ function. Initially, we studied four alternative 5ЈUTRs (Fig. 1A) , although we were only able to show expression of two and we believe these, UTRa and UTRc, to be the majority species (Fig. 1B-D) . Unlike most vertebrate 5ЈUTRs, these are relatively long (Ͼ200 nucleotides) and contain sequences with potential to confer translational regulation upon ', respectively. their mRNAs. We have demonstrated that these 5ЈUTRs directly inhibit translation of downstream reading frames (Fig. 2) , and we have determined that uORFs (Fig. 3) and stable secondary structures (Fig. 4) Fig. 1C and D) or within transcripts for a specific ER␤ isoform (Fig. 5C-E) Fig. 5C ), since these transcripts would be translated relatively efficiently (Fig. 2) [27, [43] [44] . The fact that proportions of ER␤ 5ЈUTRs differ for transcripts coding for each ER␤ isoform separately (Fig. 5) (Fig. 5D ). Cross-talk between mRNA 5Ј ends and 3Ј splicing has been reported only rarely and various models have been proposed [45] [46] . These include recruitment at specific promoters and maintenance within the extending polymerase complex of transcription factors with functions in both transcription and splicing [47] [48] . Alternatively, 5Ј mRNA structure may influence alternative splicing by controlling polymerase processivity [46, [49] [50] or by binding directly to splicing factors. It has been estimated that at least 10-18% of genes have multiple promoters [24, 51] allowing expression of alternative 5ЈUTRs and that the majority of genes show differential splicing within their coding regions [48] , therefore this regulatory cross talk may be extremely influential.
Fig. 6 Representative breast tumour TMA cores showing immunoreactivity for eIF4E (A-B), ER␤1 (C-D), ER␤2 (E-F) and ER␤5 (G-H). These cores were scored: A 3, B 7, C 3, D 7, E 3, F 7, G 3, H 7. Examples of areas of stromal cells or epithelial cancer cells are labelled 'S' or 'Ep
ER␤ deregulation in cancer
The role and expression of ER␤ in carcinogenesis is poorly understood. ER␤ appears to be anti-proliferative and pro-apoptotic, although details differ as to whether effects of each isoform result from their independent actions as transcription factors, or via hetero-dimerization with other receptors [10] [11] . Expression of ER␤1 is down-regulated during carcinogenesis in breast and colon, as one might expect for an anti-proliferative molecule, and consequently ER␤ has been discussed as a tumour suppressor [52] [53] [54] , although this may be misleading given the different functions of the other isoforms. ER␤2 appears to be up-regulated during carcinogenesis [55] [56] , while little is known about these patterns of expression of ER␤5. In terms of prognostic value, conflicting reports abound, with expression of ER␤1 but not ER␤2 [42] , or ER␤2 and 5 but not ER␤1 [28, [40] [41] being associated with good prognosis, or with ER␤2 associated with poor prognosis [57] . This suggests that these isoforms should be considered as functionally distinct receptors. Even less is known about the regulatory mechanisms responsible for the expression changes in cancer, although hypermethylation of the ER␤ promoter has been suggested as a mechanism for loss of ER␤1 expression [5, 54, (Fig. 2B) , is up-regulated in breast and lung tumours relative to matched normal tissues in the absence of up-regulation of total message (Fig. 1D) . The result is a higher proportion of translationally repressed transcripts within the total ER␤ mRNA pool, and therefore protein expression would be down-regulated within tumours, as has been reported [53] [54] 56] . A change in ratio of differentially acting 5ЈUTRs has also been implicated in the deregulation of other tumour suppressors and oncogenes, including BRCA1 [44] and Mdm2 [43] . Secondly, the translational efficiencies of ER␤ mRNAs were increased by eIF4E (Fig. 4) . This translation factor is overexpressed in a wide range of cancers [37] [38] [59] [60] , and contributes to carcinogenesis by derepressing translation of cancer-related transcripts that are otherwise inefficiently translated on account of 5ЈUTR secondary structures [21] . This mechanism allows up-regulation of ER␤ expression during carcinogenesis and is dependent on the degree of eIF4E activity. Since ER␤1 has been discussed as a tumour suppressor [52] [53] [54] Fig. 5) and demonstrated a differential response of the UTRs to eIF4E (Fig. 4) 
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